Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells

Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. Previously, we found that myeloid cell leukemia sequence 1 (Mcl1) was downregulated in DADS-induced cell cycle arrest in HL-60 human leukemia cells. Here, we investigated the role of this protein in DADS-induced...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology reports 2012-06, Vol.27 (6), p.1911-1917
Hauptverfasser: LAN YI, JI, Xiao-Xia, HUI TAN, FENG, Mei-Yan, YI TANG, LING WEN, QI SU
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1917
container_issue 6
container_start_page 1911
container_title Oncology reports
container_volume 27
creator LAN YI
JI, Xiao-Xia
HUI TAN
FENG, Mei-Yan
YI TANG
LING WEN
QI SU
description Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. Previously, we found that myeloid cell leukemia sequence 1 (Mcl1) was downregulated in DADS-induced cell cycle arrest in HL-60 human leukemia cells. Here, we investigated the role of this protein in DADS-induced G2/M cell cycle arrest in HL-60 cells. We demonstrated that DADS treatment significantly increased the proportion of G2/M phase HL-60 cells (P
doi_str_mv 10.3892/or.2012.1704
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_993103294</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>993103294</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-1dff3a7939ff20573b4ad8a35e64bcd1754b10bc9c70518db3ad16391e09da033</originalsourceid><addsrcrecordid>eNpFkE1Lw0AQhhdRrFZvniUX8WLa2Z0kmz1K0bbQ4kXFW9jsB0Q2Sd1tCv33Jrbq6R2YZ16Gh5AbChPMBZu2fsKAsgnlkJyQC8oFjVmC9LSfgdEYMf0YkcsQPgEYh0yckxFjyHMEuCDvy2bXup2pTbONWhutlaNR1US6ks7tXZ-hc7bSJq4a3SmjozmbriNlnIvUXjkTSe9N2A43i1Wcwc8qXJEzK10w18cck7fnp9fZIl69zJezx1WsMM23MdXWouQChbUMUo5lInUuMTVZUipNeZqUFEolFIeU5rpEqWmGghoQWgLimNwfeje-_er6P4q6CsMHsjFtFwohkAIykfTkw4FUvg3BG1tsfFVLvy8oFIPIovXFILIYRPb47bG4K2uj_-Bfcz1wdwRkUNJZLxtVhX8uzTHlDPAbqlF5PQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>993103294</pqid></control><display><type>article</type><title>Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>LAN YI ; JI, Xiao-Xia ; HUI TAN ; FENG, Mei-Yan ; YI TANG ; LING WEN ; QI SU</creator><creatorcontrib>LAN YI ; JI, Xiao-Xia ; HUI TAN ; FENG, Mei-Yan ; YI TANG ; LING WEN ; QI SU</creatorcontrib><description>Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. Previously, we found that myeloid cell leukemia sequence 1 (Mcl1) was downregulated in DADS-induced cell cycle arrest in HL-60 human leukemia cells. Here, we investigated the role of this protein in DADS-induced G2/M cell cycle arrest in HL-60 cells. We demonstrated that DADS treatment significantly increased the proportion of G2/M phase HL-60 cells (P&lt;0.05) and caused a time-dependent significant downregulation of Mcl1 and the cell cycle-related proteins PCNA and CDK1 (P&lt;0.05). Small interfering RNA-mediated knockdown of Mcl1 expression in HL-60 cells arrested the cell cycle in G2/M phase. By co-immunoprecipitation, we demonstrated that Mcl1 associated with PCNA and CDK1 in G2/M cell cycle arrest in DADS-treated HL-60 cells. DADS decreased the interaction of Mcl1 with PCNA and CDK1, leading to G2/M cell cycle arrest in HL-60 cells. Mcl1 plays an important role in DADS-induced G2/M cell cycle arrest in HL-60 human leukemia cells.</description><identifier>ISSN: 1021-335X</identifier><identifier>EISSN: 1791-2431</identifier><identifier>DOI: 10.3892/or.2012.1704</identifier><identifier>PMID: 22378300</identifier><language>eng</language><publisher>Athens: Spandidos</publisher><subject>Allyl Compounds - pharmacology ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; CDC2 Protein Kinase - metabolism ; Cell Cycle Proteins - metabolism ; Cell Line, Tumor ; Cell Proliferation ; Disulfides - pharmacology ; G2 Phase Cell Cycle Checkpoints - drug effects ; HL-60 Cells ; Humans ; Medical sciences ; Myeloid Cell Leukemia Sequence 1 Protein ; Proliferating Cell Nuclear Antigen - metabolism ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; RNA Interference ; RNA, Small Interfering ; Tumors</subject><ispartof>Oncology reports, 2012-06, Vol.27 (6), p.1911-1917</ispartof><rights>2015 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-1dff3a7939ff20573b4ad8a35e64bcd1754b10bc9c70518db3ad16391e09da033</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25835720$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22378300$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LAN YI</creatorcontrib><creatorcontrib>JI, Xiao-Xia</creatorcontrib><creatorcontrib>HUI TAN</creatorcontrib><creatorcontrib>FENG, Mei-Yan</creatorcontrib><creatorcontrib>YI TANG</creatorcontrib><creatorcontrib>LING WEN</creatorcontrib><creatorcontrib>QI SU</creatorcontrib><title>Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells</title><title>Oncology reports</title><addtitle>Oncol Rep</addtitle><description>Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. Previously, we found that myeloid cell leukemia sequence 1 (Mcl1) was downregulated in DADS-induced cell cycle arrest in HL-60 human leukemia cells. Here, we investigated the role of this protein in DADS-induced G2/M cell cycle arrest in HL-60 cells. We demonstrated that DADS treatment significantly increased the proportion of G2/M phase HL-60 cells (P&lt;0.05) and caused a time-dependent significant downregulation of Mcl1 and the cell cycle-related proteins PCNA and CDK1 (P&lt;0.05). Small interfering RNA-mediated knockdown of Mcl1 expression in HL-60 cells arrested the cell cycle in G2/M phase. By co-immunoprecipitation, we demonstrated that Mcl1 associated with PCNA and CDK1 in G2/M cell cycle arrest in DADS-treated HL-60 cells. DADS decreased the interaction of Mcl1 with PCNA and CDK1, leading to G2/M cell cycle arrest in HL-60 cells. Mcl1 plays an important role in DADS-induced G2/M cell cycle arrest in HL-60 human leukemia cells.</description><subject>Allyl Compounds - pharmacology</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>CDC2 Protein Kinase - metabolism</subject><subject>Cell Cycle Proteins - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Disulfides - pharmacology</subject><subject>G2 Phase Cell Cycle Checkpoints - drug effects</subject><subject>HL-60 Cells</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Myeloid Cell Leukemia Sequence 1 Protein</subject><subject>Proliferating Cell Nuclear Antigen - metabolism</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>RNA Interference</subject><subject>RNA, Small Interfering</subject><subject>Tumors</subject><issn>1021-335X</issn><issn>1791-2431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1Lw0AQhhdRrFZvniUX8WLa2Z0kmz1K0bbQ4kXFW9jsB0Q2Sd1tCv33Jrbq6R2YZ16Gh5AbChPMBZu2fsKAsgnlkJyQC8oFjVmC9LSfgdEYMf0YkcsQPgEYh0yckxFjyHMEuCDvy2bXup2pTbONWhutlaNR1US6ks7tXZ-hc7bSJq4a3SmjozmbriNlnIvUXjkTSe9N2A43i1Wcwc8qXJEzK10w18cck7fnp9fZIl69zJezx1WsMM23MdXWouQChbUMUo5lInUuMTVZUipNeZqUFEolFIeU5rpEqWmGghoQWgLimNwfeje-_er6P4q6CsMHsjFtFwohkAIykfTkw4FUvg3BG1tsfFVLvy8oFIPIovXFILIYRPb47bG4K2uj_-Bfcz1wdwRkUNJZLxtVhX8uzTHlDPAbqlF5PQ</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>LAN YI</creator><creator>JI, Xiao-Xia</creator><creator>HUI TAN</creator><creator>FENG, Mei-Yan</creator><creator>YI TANG</creator><creator>LING WEN</creator><creator>QI SU</creator><general>Spandidos</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120601</creationdate><title>Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells</title><author>LAN YI ; JI, Xiao-Xia ; HUI TAN ; FENG, Mei-Yan ; YI TANG ; LING WEN ; QI SU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-1dff3a7939ff20573b4ad8a35e64bcd1754b10bc9c70518db3ad16391e09da033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Allyl Compounds - pharmacology</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>CDC2 Protein Kinase - metabolism</topic><topic>Cell Cycle Proteins - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Disulfides - pharmacology</topic><topic>G2 Phase Cell Cycle Checkpoints - drug effects</topic><topic>HL-60 Cells</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Myeloid Cell Leukemia Sequence 1 Protein</topic><topic>Proliferating Cell Nuclear Antigen - metabolism</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>RNA Interference</topic><topic>RNA, Small Interfering</topic><topic>Tumors</topic><toplevel>online_resources</toplevel><creatorcontrib>LAN YI</creatorcontrib><creatorcontrib>JI, Xiao-Xia</creatorcontrib><creatorcontrib>HUI TAN</creatorcontrib><creatorcontrib>FENG, Mei-Yan</creatorcontrib><creatorcontrib>YI TANG</creatorcontrib><creatorcontrib>LING WEN</creatorcontrib><creatorcontrib>QI SU</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oncology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LAN YI</au><au>JI, Xiao-Xia</au><au>HUI TAN</au><au>FENG, Mei-Yan</au><au>YI TANG</au><au>LING WEN</au><au>QI SU</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells</atitle><jtitle>Oncology reports</jtitle><addtitle>Oncol Rep</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>27</volume><issue>6</issue><spage>1911</spage><epage>1917</epage><pages>1911-1917</pages><issn>1021-335X</issn><eissn>1791-2431</eissn><abstract>Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. Previously, we found that myeloid cell leukemia sequence 1 (Mcl1) was downregulated in DADS-induced cell cycle arrest in HL-60 human leukemia cells. Here, we investigated the role of this protein in DADS-induced G2/M cell cycle arrest in HL-60 cells. We demonstrated that DADS treatment significantly increased the proportion of G2/M phase HL-60 cells (P&lt;0.05) and caused a time-dependent significant downregulation of Mcl1 and the cell cycle-related proteins PCNA and CDK1 (P&lt;0.05). Small interfering RNA-mediated knockdown of Mcl1 expression in HL-60 cells arrested the cell cycle in G2/M phase. By co-immunoprecipitation, we demonstrated that Mcl1 associated with PCNA and CDK1 in G2/M cell cycle arrest in DADS-treated HL-60 cells. DADS decreased the interaction of Mcl1 with PCNA and CDK1, leading to G2/M cell cycle arrest in HL-60 cells. Mcl1 plays an important role in DADS-induced G2/M cell cycle arrest in HL-60 human leukemia cells.</abstract><cop>Athens</cop><pub>Spandidos</pub><pmid>22378300</pmid><doi>10.3892/or.2012.1704</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1021-335X
ispartof Oncology reports, 2012-06, Vol.27 (6), p.1911-1917
issn 1021-335X
1791-2431
language eng
recordid cdi_proquest_miscellaneous_993103294
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Allyl Compounds - pharmacology
Antineoplastic Agents - pharmacology
Biological and medical sciences
CDC2 Protein Kinase - metabolism
Cell Cycle Proteins - metabolism
Cell Line, Tumor
Cell Proliferation
Disulfides - pharmacology
G2 Phase Cell Cycle Checkpoints - drug effects
HL-60 Cells
Humans
Medical sciences
Myeloid Cell Leukemia Sequence 1 Protein
Proliferating Cell Nuclear Antigen - metabolism
Proto-Oncogene Proteins c-bcl-2 - genetics
Proto-Oncogene Proteins c-bcl-2 - metabolism
RNA Interference
RNA, Small Interfering
Tumors
title Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A29%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Involvement%20of%20Mcl1%20in%20diallyl%20disulfide-induced%20G2/M%20cell%20cycle%20arrest%20in%20HL-60%20cells&rft.jtitle=Oncology%20reports&rft.au=LAN%20YI&rft.date=2012-06-01&rft.volume=27&rft.issue=6&rft.spage=1911&rft.epage=1917&rft.pages=1911-1917&rft.issn=1021-335X&rft.eissn=1791-2431&rft_id=info:doi/10.3892/or.2012.1704&rft_dat=%3Cproquest_cross%3E993103294%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=993103294&rft_id=info:pmid/22378300&rfr_iscdi=true